|
Press Releases |
|
 |
|
Friday, November 15, 2019 |
|
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats |
Global BioLife Inc, the U.S.subsidiary of SGX-listed Singapore eDevelopment Ltd (SeD), will present research on its 3F Antimicrobial Fragrance as a new method to prevent and treat Tuberculosis at the 2020 ASM Biothreats conference, taking place from 28 to 30 January 2020 in Arlington, Virginia. more info >> |
|
Tuesday, October 29, 2019 |
|
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis |
SGX-listed Singapore eDevelopment Limited ("SeD", SGX:40V) wishes to announce that its biomedical subsidiary incorporated in Nevada, Global BioLife Inc. ("Global BioLife") will be presenting its research on its Functional Fragrance Formula ("3F") against tuberculosis at the 2020 American Society for Microbiology ("ASM") Biothreats Conference. more info >> |
|
Wednesday, July 24, 2019 |
|
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit |
SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce the results of clinical trials conducted on Laetose(TM), developed by its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"). more info >> |
|
Wednesday, June 12, 2019 |
|
Global BioLife's 3F Mosquito Repellent Formula performs well in Independent Testing |
SGX-listed Singapore eDevelopment Ltd (SeD) wishes to announce that its U.S. biomedical subsidiary Global BioLife Inc. has independently tested its new 3F Mosquito Formula which performs well against mosquitoes for six (6) to eight (8) hours. more info >> |
|
Monday, January 28, 2019 |
|
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis |
SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis. more info >> |
|
Wednesday, November 7, 2018 |
|
Singapore eDevelopment's Global BioLife to present Parkinson's Research at Neuroscience 2018 |
Singapore eDevelopment (SGX: 40V) ("SeD") subsidiary, Global BioLife Inc. is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the International Society for Neuroscience (SfN) in San Diego, California. more info >> |
|
Monday, June 18, 2018 |
|
Singapore eDevelopment Limited Announces Corporate and Business Update |
The Board of Directors of Singapore eDevelopment Limited wishes to provide shareholders an update on the Group's operations. more info >> |
|
Thursday, May 31, 2018 |
|
Singapore eDevelopment's Global BioLife develops Low Glycemic Modified Sugar |
Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife, Inc. ("Global BioLife"), has developed a low glycemic index, naturally modified sugar - Laetose - which has the potential to affect the world's sugar market. more info >> |
|
Thursday, March 1, 2018 |
|
Singapore eDevelopment's Global BioLife confirms LB2 efficacy against Ebola |
Singapore eDevelopment (SGX: 40V; SeD) is pleased to announce biomedical subsidiary Global BioLife, Inc. has completed the initial Zaire Ebola research portion for the study of new anti-viral drug LB2, part of its new universal therapeutic drug platform, Linebacker. more info >> |
|
Wednesday, November 1, 2017 |
|
Singapore eDevelopment's Global BioLife confirms 100% Repellency of 3F Mosquito Fragrance |
SGX-listed Singapore eDevelopment Ltd (SeD) announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has completed development and testing of mosquito deterring technologies including fragrances, paints, and fabric. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
翼菲科技衝刺港股:輕工業機器人先鋒 全棧技術驅動商業化潛力可期
Jul 8, 2025 11:05 HKT/SGT
|
|
|
翼菲科技冲刺港股:轻工业机器人先锋 全栈技术驱动商业化潜力可期
Jul 8, 2025 10:52 HKT/SGT
|
|
|
エーザイ、CDP から「サプライヤー・エンゲージメント評価」において最高評価である「サプライヤー・エンゲージメント・リーダー」に選定
Jul 8, 2025 09:00: JST
|
|
|
Eisai Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment
Jul 8, 2025 9:31 JST
|
|
|
Progress towards potassium-ion batteries
Jul 8, 2025 06:48 HKT/SGT
|
|
|
Kincora Secures Strategic North American Investors and Announces Private Placement
Jul 8, 2025 06:39 HKT/SGT
|
|
|
Small Businesses Embrace Social -- But Could be Missing a Trick in the Age of AI
Jul 8, 2025 06:00 HKT/SGT
|
|
|
15 World Toppers and Near-Perfect Scorers for GIIS Singapore in IBDP 2025 Exams
Jul 7, 2025 23:14 HKT/SGT
|
|
|
GIIS新加坡校區15名學生在2025年IBDP考試中榮登世界榜首及近滿分成績
Jul 7, 2025 12:00 HKT/SGT
|
|
|
GIIS新加坡校区15名学生在2025年IBDP考试中荣登世界榜首及近满分成绩
Jul 7, 2025 12:00 HKT/SGT
|
|
|
三菱重工、北海道電力苫東厚真発電所向け国内最大規模のCO₂回収設備の基本設計を受注
Jul 7, 2025 11:30: JST
|
|
|
アリックスパートナーズ、2025年版グローバル・リスク調査の結果を発表
Jul 7, 2025 11:00: JST
|
|
|
Huatai Foundation Supports NbS Summer School, Convening Global Youth to Tackle Ecological Conservation
Jul 7, 2025 10:44 HKT/SGT
|
|
|
凝聚全球青年生態保護智慧 華泰公益基金會支持NbS暑期學校
Jul 7, 2025 10:28 HKT/SGT
|
|
|
MHI Awarded Contract for Basic Design of Japan's Largest CO2 Capture Plant at Hokkaido Electric Power's Tomato-Atsuma Power Station
Jul 7, 2025 11:15 JST
|
|
|
|
More News >> |
|
|
|
|
|